Robert Pola

2.2k total citations
58 papers, 1.4k citations indexed

About

Robert Pola is a scholar working on Biomaterials, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Robert Pola has authored 58 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Biomaterials, 26 papers in Biomedical Engineering and 22 papers in Molecular Biology. Recurrent topics in Robert Pola's work include Nanoparticle-Based Drug Delivery (30 papers), Nanoplatforms for cancer theranostics (21 papers) and RNA Interference and Gene Delivery (12 papers). Robert Pola is often cited by papers focused on Nanoparticle-Based Drug Delivery (30 papers), Nanoplatforms for cancer theranostics (21 papers) and RNA Interference and Gene Delivery (12 papers). Robert Pola collaborates with scholars based in Czechia, Germany and Netherlands. Robert Pola's co-authors include Michal Pechar, Karel Ulbrich, Tomáš Etrych, Twan Lammers, Gert Storm, Fabian Kießling, Felix Gremse, Benjamin Theek, Sijumon Kunjachan and Olga Janoušková and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nano Letters and ACS Nano.

In The Last Decade

Robert Pola

56 papers receiving 1.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Robert Pola 691 647 529 193 183 58 1.4k
Xinghai Li 775 1.1× 432 0.7× 629 1.2× 134 0.7× 177 1.0× 36 1.5k
In-San Kim 712 1.0× 639 1.0× 587 1.1× 90 0.5× 153 0.8× 16 1.4k
James Z. Hui 610 0.9× 700 1.1× 550 1.0× 212 1.1× 112 0.6× 15 1.4k
Marloes M. J. Kamphuis 682 1.0× 419 0.6× 535 1.0× 80 0.4× 155 0.8× 25 1.5k
Hiroyasu Takemoto 560 0.8× 436 0.7× 850 1.6× 125 0.6× 146 0.8× 49 1.4k
Nicholas L. Fletcher 685 1.0× 444 0.7× 546 1.0× 136 0.7× 376 2.1× 79 1.5k
Andrew J. Simnick 1.1k 1.6× 642 1.0× 650 1.2× 78 0.4× 156 0.9× 10 1.8k
Bryan Hoang 636 0.9× 452 0.7× 289 0.5× 116 0.6× 122 0.7× 17 985
Anjan Nan 618 0.9× 384 0.6× 495 0.9× 196 1.0× 176 1.0× 25 1.3k
Andrew S. Mikhail 520 0.8× 556 0.9× 228 0.4× 157 0.8× 196 1.1× 46 1.2k

Countries citing papers authored by Robert Pola

Since Specialization
Citations

This map shows the geographic impact of Robert Pola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Pola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Pola more than expected).

Fields of papers citing papers by Robert Pola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Pola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Pola. The network helps show where Robert Pola may publish in the future.

Co-authorship network of co-authors of Robert Pola

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Pola. A scholar is included among the top collaborators of Robert Pola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Pola. Robert Pola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pola, Robert, Michal Pechar, Libor Kostka, et al.. (2025). Nanomedicines for Delivery of Cytarabine: Effect of Carrier Structure and Spacer on the Anti-Lymphoma Efficacy. Polymers. 17(21). 2837–2837.
2.
Shan, Xiaoning, Robert Pola, Daulet B. Kaldybekov, et al.. (2025). Development of maleimide-modified poly(N-(2-hydroxylpropyl)methacrylamide) as a novel mucoadhesive polymer for nasal drug delivery. European Polymer Journal. 237. 114193–114193.
3.
Chen, Junlin, Eva Miriam Buhl, Robert Pola, et al.. (2024). RGD-coated polymeric microbubbles promote ultrasound-mediated drug delivery in an inflamed endothelium-pericyte co-culture model of the blood-brain barrier. Drug Delivery and Translational Research. 14(10). 2629–2641. 3 indexed citations
5.
Konefał, Rafał, Robert Pola, Volodymyr Lobaz, et al.. (2024). Dual Thermo- and pH-Responsive Polymer Nanoparticle Assemblies for Potential Stimuli-Controlled Drug Delivery. ACS Applied Bio Materials. 8(1). 271–284. 5 indexed citations
6.
Pola, Robert, Michal Pechar, Jan Pankrác, et al.. (2023). Stimuli‐Responsive Polymer Nanoprobes Intended for Fluorescence‐Guided Surgery of Malignant Head‐and‐Neck Tumors and Metastases. Advanced Healthcare Materials. 12(28). e2301183–e2301183. 3 indexed citations
7.
Pola, Robert, Jiří Trousil, Michal Pechar, et al.. (2023). Polymer-Antimicrobial Peptide Constructs with Tailored Drug-Release Behavior. Pharmaceutics. 15(2). 406–406. 9 indexed citations
8.
Kirakci, Kaplan, Robert Pola, Michal Pechar, et al.. (2023). Radiosensitizing molybdenum iodide nanoclusters conjugated with a biocompatible N-(2-hydroxypropyl)methacrylamide copolymer: a step towards radiodynamic therapy. Materials Advances. 4(23). 6389–6395. 1 indexed citations
9.
Schulte, Anna, Andrés de los Santos Pereira, Robert Pola, et al.. (2023). On‐Demand Cell Sheet Release with Low Density Peptide‐Functionalized Non‐LCST Polymer Brushes. Macromolecular Bioscience. 23(3). e2200472–e2200472. 3 indexed citations
10.
Möckel, Diana, Matthias Bartneck, Patricia M. Niemietz, et al.. (2023). CCL2 chemokine inhibition primes the tumor vasculature for improved nanomedicine delivery and efficacy. Journal of Controlled Release. 365. 358–368. 13 indexed citations
11.
Filipová, Marcela, et al.. (2022). The Transmission and Toxicity of Polymer-Bound Doxorubicin-Containing Exosomes Derived from Human Adenocarcinoma Celxdls. Nanomedicine. 17(19). 1307–1322. 2 indexed citations
12.
Nakamura, Hideaki, et al.. (2021). Acid-responsive HPMA copolymer-bradykinin conjugate enhances tumor-targeted delivery of nanomedicine. Journal of Controlled Release. 337. 546–556. 14 indexed citations
13.
Kašpar, Ondřej, Vlastimil Král, Michal Pechar, et al.. (2020). Functionalized hydrogel microparticles prepared by microfluidics and their interaction with tumour marker carbonic anhydrase IX. Soft Matter. 16(37). 8702–8709. 6 indexed citations
14.
Ergen, Can, Patricia M. Niemietz, Felix Heymann, et al.. (2019). Liver fibrosis affects the targeting properties of drug delivery systems to macrophage subsets in vivo. Biomaterials. 206. 49–60. 20 indexed citations
15.
Pola, Robert, et al.. (2016). Peptide-Targeted Polymer Cancerostatics. Physiological Research. 65(Suppl 2). S153–S164. 4 indexed citations
16.
Ergen, Can, Felix Heymann, Wa’el Al Rawashdeh, et al.. (2016). Targeting distinct myeloid cell populations in vivo using polymers, liposomes and microbubbles. Biomaterials. 114. 106–120. 65 indexed citations
17.
Theek, Benjamin, Felix Gremse, Sijumon Kunjachan, et al.. (2014). Characterizing EPR-mediated passive drug targeting using contrast-enhanced functional ultrasound imaging. Journal of Controlled Release. 182. 83–89. 83 indexed citations
18.
Pola, Robert, Martin Studenovský, Michal Pechar, et al.. (2009). HPMA-copolymer conjugates targeted to tumor endothelium using synthetic oligopeptides. Journal of drug targeting. 17(10). 763–776. 16 indexed citations
19.
Carlisle, Robert, et al.. (2008). Development of hydrophilic polymers to reduce the interaction of adenovirus type 5 with human blood components. Human Gene Therapy. 19. 399–399. 1 indexed citations
20.
Lammers, Twan, Rainer Kühnlein, Maria Kissel, et al.. (2005). Effect of physicochemical modification on the biodistribution and tumor accumulation of HPMA copolymers. Journal of Controlled Release. 110(1). 103–118. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026